DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: Drug Interaction for HCV Post Liver Transplant – Debate – PRO

For ILTS members only, please join now or renew your membership.

• 

  LONG-TERM OUTCOMES: Long Term Outcomes of Multi-Organ Transplantation

  For ILTS members only, please join now or renew your membership.
• 

  ACUTE LIVER FAILURE: What Are the Options When Time is Running Out?

  For ILTS members only, please join now or renew your membership.
• 

  :RISK EVALUATION AND OUTCOMES: Is Physiological Reserve Measurement the Best Predictor of Outcomes ?

  For ILTS members only, please join now or renew your membership.

• 

  Working Groups for Immunosuppression Guidance: Immunosuppression Minimization Strategies

  For ILTS members only, please join now or renew your membership.
• 

  HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: Interferon-free Regimens Pre- and Post-Transplant

  For ILTS members only, please join now or renew your membership.
• 

  Hepatology Update: Non-Alcoholic Fatty Liver Disease (NAFLD) and

  For ILTS members only, please join now or renew your membership.